COLORADO SPRINGS, CO / ACCESSWIRE / October 31, 2019 / As playwright Oscar Wilde famously said, "Life imitates art far more than art imitates life." In essence, Wilde contended that people find beauty in life and the world based on what artists have taught them to seek out and find. Similarly, Wilde held that the "self-conscious aim of Life is to find expression and that Art offers it certain beautiful forms through which it may realize that energy." Taking a page from Wilde's playbook, Colorado Springs, CO, resident, trial skills specialist, and former actor Jesse Wilson helps others find beauty and bravery in themselves through creative expression and artistic principles.

A graduate of the Juilliard School with a 20-year career in TV, film, and theater, Jesse Wilson could easily have used his trove of talent and expertise for his sole benefit. Instead, though, the communications specialist, speaking coach, trial skills consultant, and CEO is helming a movement to help others realize their authentic selves and maximize their potential. Founder of Tell The Winning Story, Jesse Wilson empowers people from all walks of life, from prison inmates to high-profile lawyers and businesspeople.

"Tell The Winning Story doesn't just help heal the ‘victims' in plaintiffs' or defendants' criminal cases, but the lawyers as well, many who are battling addictions and mental illnesses themselves," Jesse Wilson said.

Discussing what he refers to as the "hidden masks" of lawyers, Jesse Wilson explained one of the most powerful communication tools he works in trial advocacy and skills training helps attorneys "get out of their own way" to realize their true potential and power as great communicators. One of the ways in which he does this is through Character and Neutral masks, the origin of which goes back to ancient Greece, in a time when theater and law were closely linked.

"From my early training studying theatre at The Juilliard School in New York City, the use of masks has been shared with hundreds of people I've worked within the arena of effective presentation, breakthrough communication, and human connection," he said. "I believe there is a greater role and a greater story hidden behind the masks we wear in life. With the lessons from the stage, my mission is to empower people to discover that within each of all of us is the power to unmask our hidden, raw potential and transform that authentic power into the greatest realization of ourselves in virtually every area of our lives."

Jesse Wilson provides various communication and presentation training opportunities, including seminars, law firm retreats, intensives, and group workshops. To learn more about him and his company, visit the Tell The Winning Story website: https://www.tellthewinningstory.com/

CONTACT:
Caroline Hunter
Web Presence, LLC
+1 7865519491

SOURCE: Web Presence, LLC

ReleaseID: 564844

NEW YORK, NY / ACCESSWIRE / October 31, 2019 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Twitter, Inc. ("Twitter" or the "Company") (NYSE:TWTR) and certain of its officers, on behalf of shareholders who purchased Twitter securities between August 6, 2019 and October 23, 2019, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site:www.bgandg.com/twtr.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.

The Complaint alleges that, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) while Twitter represented that it "fixed" certain issues relating to user choice settings designed to target advertising were not working as intended; (2) the changes implemented to fix these issues adversely affected Twitter's ability to target advertising, including the targeting of advertising through its Mobile App Promotion ("MAP") product, which caused a material decline in advertising revenue; and (3) as a result, Twitter's public statements were materially false and misleading at all relevant times.

If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/twtr or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Twitter you have until December 30, 2019 to request that the Court appoint you as lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz

212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 564845

HAPPY VALLEY, OR / ACCESSWIRE / October 31, 2019 / The founder of the first online weight loss program, Committed 100, Chad Tackett, says, "The key to stopping intense night cravings is by turning them into fat-burning sessions."

Food cravings and hunger pains are not unusual to experience when trying to shed pounds. They often occur hours after dinner. It is an intense desire for something sweet and delicious. It is usually food that does not support weight-loss.

Chad Tackett says there are a few ways to kick those sugar cravings to the curb.

Preparation is key. Most know that healthy foods increase the likelihood of weight-loss and that they should be incorporated into various meals throughout the day.

Taking precautions is also essential. Avoiding the candy-filled vending machines at work and sugary commercials at home can lessen temptations.

Avoidance is helpful in the process of losing weight. Packing lunch is also a smart option. It will help cut out the opportunities to eat fast foods.

Chad Tackett believes planning is a big part of pushing night cravings away.

But, sometimes, these methods do not always work. There will come a time when cravings win, and persistence does not pay off. A frantic search for something sweet to quench the intense desire is inevitable.

And the often terrible feeling that follows it occurs.

Committed 100's founder says, "Do not stress. The answer is to get back on track." The lack of willpower might interrupt the weight-loss process, but it does not have to ruin all the reasonable efforts before caving.

Chad Tackett says, "Sugar is highly addictive and easily attainable. Caving to the craving, from time to time, is not your fault."

He also insists on not making a small slip up to become a habit. Do not allow the same scenario to play out, on repeat, every night.

Instead, make healthier versions of the desired sweets. Alternative foods that have the same effect help rid the feeling of being deprived of certain foods.

"Be realistic," says Chad Tackett.

Chose to combine the right ingredients to support healthy fat loss, rather than sabotage it.

It is also essential to eat slowly and intently. In doing so, Chad Tackett says, "You will feel full and satisfied after a small portion – just enough to curb the craving."

Choose to also drink a lot of regular or flavored water. Water is also helpful in making the stomach feel full without the need to overload on empty calories.

These methods will satisfy cravings. They will contribute to feeling energized and empowered, rather than guilty, bloated, and lethargic.

Night cravings, they are real. Do not deny them.

When trying to lose weight, expect food cravings to be a part of the process. Instead of denying them, use helpful methods that further subdue the intense cravings.

Learn more about the game-changing online weight loss program, Committed 100, by exploring their website: http://www.committed100.com/

CONTACT:

Caroline Hunter
Web Presence, LLC
+1 7865519491

SOURCE: Web Presence, LLC

ReleaseID: 564840

RALEIGH, NC / ACCESSWIRE / October 31, 2019 / Issuer Direct Corporation (NYSE American:ISDR), an industry-leading communications and compliance company, today announced as part of its strategic plan, it has made key hires in North America to ramp its platform business in 2020 and beyond.

Key hires include three industry veterans with an average of 12 years of experience, directly related to the company's communications and platform business, specifically its ACCESSWIRE product offering. These executives will be located in strategic locations including Boston, New York and Philadelphia. Additionally, the company also added two Business Development Managers with B2B subscription experience to help further market the company's platform.

Executive VP of Sales, Dick Bromley, commented on the expansion, "It's an exciting time to be working at Issuer Direct and I'm thrilled to be able to add five new experienced hires to the team. Their experience and tenure within the newswire industry will benefit our ever expanding list of customers and allow us to continue on our trajectory as the fastest growing newswire in North America. We are proud to disrupt an industry that has scarcely changed over the last two decades and believe passionately about delivering an exceptional customer experience, at a fraction of the cost. These new hires are well-known within the industry we serve and will further enhance our reputation".

Brian Balbirnie, CEO of Issuer Direct, stated, "We have begun the critical next steps in our newswire distribution business, having recently added marquee trading platforms like E-Trade and TD Ameritrade, that further enhance our distribution. We have invested extensively in our news platform, with people, infrastructure and distribution, and we have always said once we reach a point where our distribution has grown, we would then invest in the business with additional key hires in our sales organization. That time is now. We are bullish on our customer growth and know it's just a matter of time before the ends of our distribution network are filled out and complete."

These key hires increase the company's Sales organization to 19 professionals or approximately 25% of the company's total headcount.

The company also expects to hire key employees by year end to further invest in its Conference Platform.

About Issuer Direct Corporation

Issuer Direct® is an industry-leading communications and compliance company focusing on the needs of corporate issuers. Issuer Direct's principal platform, Platform id.™, empowers users by thoughtfully integrating the most relevant tools, technologies, and services, thus eliminating the complexity associated with producing and distributing financial and business communications. Headquartered in Raleigh, NC, Issuer Direct has served more than 4,000 public and private companies in more than 18 countries. For more information, please visit www.issuerdirect.com.

For Further Information:

Issuer Direct Corporation
Brian R. Balbirnie
919-481-4000
brian.balbirnie@issuerdirect.com

Brett Maas
Hayden IR
(646) 536-7331
brett@haydenir.com

James Carbonara
Hayden IR
(646)-755-7412
james@haydenir.com

SOURCE: Issuer Direct Corporation

ReleaseID: 564843

MIAMI, FL / ACCESSWIRE / October 31, 2019 / American Diversified Holdings Corp. (OTC PINK:ADHC) https://americandiversifiedholding.com through its operating subsidiary Imperbe SL www.imperbe.es an industrial & commercial roof and flooring infrastructure and its management Company are proudly announcing results of a contract signed and started in Germany.

The CEO of Imperbe and ADHC shared details about the project and expected revenues. "The firm deployed 7 employees who worked on the 5,000 m2 of asphalt sheet and 2,000 m2 of 10 cm thermal insulation" Albert stated.

ADHC's CEO is expecting to sign a few more important contracts as the results of the existing project are astonishing. "Since the work carried out by Imperbé, left the client very satisfied we are now expecting to sign the 2nd contract of about the same value."

Recently, the same client hired Imperbe for another similar job in the town of Frankfurt (Germany) worth about € 160,000 of 6,800 m2 of current roof disassembly and placement of two new asphalt sheets plus a 10 cm thick thermal insulation. Imperbé continues to work tirelessly on new projects. The roofing company is a very important and strong link in the ADHC, as they continuously have new arrangements and projects with the value of hundreds of thousands. CEO Albert Vendrell Juncosa personally inspects these projects and supervises them in order to assure that the construction site and whole project are developing as planned. The company expects to attract other similar and significant contracts in the upcoming quarter and beyond.

More details will follow on a timely basis.

Safe Harbor Statement:

Information in this news release may contain statements about future expectations, plans, prospects or performance of American Diversified Holdings Corp. that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. American Diversified Holdings Corp. cautions you that any forward-looking information provided by or on behalf of American Diversified Holdings Corp. is not a guarantee of future performance. None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind. American Diversified Holdings Corp.'s actual results may differ materially from those anticipated in such forward- looking statements as a result of various important factors, some of which are beyond American Diversified Holdings Corp.'s control. In addition to those discussed in American Diversified Holdings Corp.'s press releases, public filings, and statements by American Diversified Holdings Corp.'s management, including, but not limited to, American Diversified Holdings Corp.'s estimate of the sufficiency of its existing capital resources, American Diversified Holdings Corp.'s ability to raise additional capital to fund future operations, American Diversified Holdings Corp.'s ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities and, in identifying contracts which match American Diversified Holdings Corp.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. American Diversified Holdings Corp. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

Contact:

Daniel Sobolewski, +1 720 500 2224

Web: https://americandiversifiedholding.com/

Email: ir@americandiversifiedholding.com

Twitter: https://twitter.com/AdhcCorp

SOURCE: American Diversified Holding Corp.

ReleaseID: 564838

SCOTTSDALE, AZ / ACCESSWIRE / October 31, 2019 / Life365, a leader in integrated health solutions, announced today that J & B Medical, one of the nation's fastest-growing healthcare organizations, and their telehealth solutions subsidiary, HNC Virtual Solutions, has joined the consortium of partners on the Life365 Integrated Health Solution Platform. J & B Medical and HNC Virtual Solutions are joining American Medical Response (AMR) and Life365 to offer new integrated virtual care solutions to several large providers and payers across the US.

The Life365 Platform addresses the need to consolidate a variety of services and solutions into a common virtual care offering to enterprise clients. With a focus on organizations that are financially responsible for the care of high-volume patient and member populations, Life365 fulfills the need to deliver a broader, more diverse, range of solutions and services beyond the traditional point of care. Digital health solutions and accompanying services have historically been fragmented, requiring clients to manage multiple vendor relationships in a disorganized manner, resulting in substantial costs in time and money, thus preventing scalability.

The Life365 platform uses its Interoperability Engine (IE) and Personalyze™ (AI) to streamline integration and intelligently select and deploy the right combination of solutions to patients yielding the best engagement and outcomes at the right economics. Life365 fills the need for "one hand to shake" when connecting providers to patients outside the clinical setting. Life365's integrated solution partners provide digital health products, clinical backend integration, warm health services, behavioral health, social determinants, chronic care management, episodic care, proactive health & wellness and more.

Partners in Virtual Care

Life365 integrates a variety of digital health solutions and virtual care services to change the dynamics of healthcare by improving efficiency, transparency and access to care on a common curated platform. "The Life365 Integrated Health Solutions Platform allows our clients to now consider the patient's home as an extension of their enterprise, enabling care delivery in rural and underserved areas economically, while eliminating the need to build costly facilities", said Kent Dicks, CEO of Life365. "As we move toward more value based care, it's even more important to provide greater access to care across larger populations of patients in a scalable manner."

"J & B Medical prides itself on being a premium ‘one stop shop' for a large client base," said Stephen Shaya, M.D. of J & B Medical. "Our customers are always looking for ways we can bring more solutions and services to the 3 million people we serve every day. We believe that being integrated in the Life365 Platform enables us to offer providers with a wider range of goods and services – cafeteria-style – bringing more value to them and their members with a more personalized offering."

"HNC Virtual Solutions is proud to partner with Life365 to serve a growing population with an integrated solutions offering," said Dr. Fawzi Shaya, CEO of HNC Virtual Solutions. "We believe that with HNC and J & B Medical integrated into the Life365 platform, we will deliver the value and scalability that is being demanded by payers, providers, retail pharmacies and clinics throughout the US and around the world. "Virtual care is moving to increase access to quality care and reducing overall healthcare costs, and we believe it starts with partnerships such as this one."

###

About Life365

Life365 is a fully interoperable, scalable, multi-channel Integrated Health Platform that facilitates solution and service deployment for healthcare systems addressing self-managed patient care at home. Life365's patent portfolio is centered around scaling digital health solutions to larger populations of patients through unique and innovative processes (e.g. ultralight / disposable tech, AI-driven functionality, cloud-connected sensors). Life365's team members have over a decade of experience and thought leadership in the Digital Health space. For more information regarding Life365, please visit www.life365.health.

About J & B Medical

J & B Medical is a family-owned and privately-held, nationally recognized Women's Business Enterprise and global healthcare organization. Founded in 1996 by Dr. Fawzi and Mary Shaya, J & B Medical's 16 different business enterprises have solidified them as one of the largest providers of consumable medical products, with medical distribution from 953 manufacturers and customers in 48 states and 28 countries, and specialty distribution, such as veterinary and emergency medical supplies. J & B's programs have been globally recognized for improving clinical outcomes and quality of life with significant cost savings. For more information regarding J & B Medical, please visit www.jandbmedical.com.

About HNC Virtual Solutions

HNC Virtual Solutions is a fast-paced, highly focused telemedicine development solutions company whose primary focus is to design and implement advanced telemedicine and remote patient monitoring. HNC is composed of skilled system engineers, programmers, project specialists, and organizational managers dedicated to the progression of available healthcare for all. As a proud member of the J & B Medical – HNC knows technology and medicine. For more information regarding HNC Virtual Solutions, please visit www.hncvirtualsolutions.com.

JV Public Relations NYC, Inc.
(212) 645-5498
jvasquez@jvprny.com

SOURCE: Life365

ReleaseID: 564826

NEW YORK, NY / ACCESSWIRE / October 31, 2019 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AMAG Pharmaceuticals, Inc. ("AMAG" or the "Company") (NASDAQ:AMAG). Investors who purchased AMAG stock are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/amag.

The investigation concerns whether AMAG and certain of its officers and/or directors have violated federal securities laws.

On October 29, 2019, AMAG announced that the Food and Drug Administration's ("FDA") Bone, Reproductive and Urologic Drugs Advisory Committee had voted 16-0 that the Company's confirmatory study, Trial 003, failed to demonstrate the effectiveness of AMAG's Makena product in reducing the risk of preterm births in women with histories of singleton spontaneous preterm birth. The FDA committee also voted 13-3 that the clinical data (Trials 002 and 003) in the Company's application failed to demonstrate substantial evidence of effectiveness. On this news, AMAG's stock price fell $2.98 per share, or 22.36%, to close at $10.35 per share on October 30, 2019.

If you are aware of any facts relating to this investigation, or purchased AMAG shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/amag. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 564842

NEW YORK, NY / ACCESSWIRE / October 31, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Uniti Group Inc. (NASDAQGS:UNIT)

Investors Affected : April 20, 2015 – February 15, 2019

A class action has commenced on behalf of certain shareholders in Uniti Group Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Uniti's financial results were not sustainable because its customer Windstream had defaulted on its unsecured notes; and (ii) as a result of the foregoing, Defendants' statements about Uniti's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/uniti-group-inc-loss-submission-form/?id=4121&from=1

Tencent Music Entertainment Group (NYSE:TME)

Investors Affected : December 12, 2018 – August 26, 2019

A class action has commenced on behalf of certain shareholders in Tencent Music Entertainment Group. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Tencent Music's exclusive licensing arrangements with major record labels were anticompetitive; (2) consequently, sublicensing such content from Tencent Music was unreasonably expensive, in violation of Chinese antimonopoly laws; (3) these anticompetitive efforts were reasonably likely to lead to regulatory scrutiny; and (4) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/tencent-music-entertainment-group-loss-submission-form/?id=4121&from=1

iRobot Corporation (NASDAQ:IRBT)

Investors Affected : November 21, 2016 – October 22, 2019

A class action has commenced on behalf of certain shareholders in iRobot Corporation. The filed complaint alleges that defendants misrepresented the reason for iRobot's acquisitions of Tokyo-based Sales on Demand Corporation and privately-held Robopolis SAS, which was to control the Company's largest distributors so that defendants could inflate sales and revenue figures by stuffing the channel. Defendants further misled investors by repeatedly telling them throughout the Class Period that the Company was seeing continued double-digit revenue growth, and by attributing the growth to increased demand for the Roomba vacuums, when in reality defendants were engaging in channel-stuffing to artificially boost sales. Defendants also misstated that the Company's channel inventory levels had not changed and would not change dramatically from quarter to quarter or year over year, when in fact iRobot was deliberately stuffing the channel in order to claim false revenue growth.

Shareholders may find more information at https://securitiesclasslaw.com/securities/irobot-corporation-loss-submission-form/?id=4121&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 564841

NEW YORK, NY / ACCESSWIRE / October 31, 2019 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Catalyst Pharmaceuticals, Inc. ("Catalyst" or the "Company") (NASDAQ:CPRX). Investors who purchased Catalyst stock are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/cprx.

The investigation concerns whether Catalyst and certain of its officers and/or directors have violated federal securities laws.

On October 30, 2019, Catalyst issued a press release announcing "top-line results from CMS-001, a Phase 3 study evaluating amifampridine phosphate for the symptomatic treatment of genetically confirmed Congenital Myasthenic Syndromes (CMS) in adults and children aged 2 years and above." The press release advised investors that "[w]hile individual patient improvements were observed in some patient sub-groups, the trial did not meet its primary endpoint of subject global impression (SGI) or the secondary endpoint of muscle function measure (MFM) across all tested subtypes." On this news, Catalyst's stock price fell $0.74 per share, or 12.98%, to close at $4.96 per share on October 30, 2019.

If you are aware of any facts relating to this investigation, or purchased Catalyst shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/cprx. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 564839